Ridge Bio
About
What does Ridge Bio do?
Ridge Bio is a biotechnology company focused on developing transformative gene therapies for patients with rare genetic diseases. Their platform aims to deliver precise and effective treatments by leveraging advanced gene editing and delivery technologies. The company is dedicated to addressing unmet medical needs and improving the lives of individuals affected by debilitating genetic conditions.
What is Ridge Bio's revenue?
StartupHub estimates Ridge Bio's annual revenue at $58.5M (range $7.8M to $133.9M, 29% confidence), based on comparable companies in the sector.
What is Ridge Bio's valuation?
StartupHub estimates Ridge Bio's effective valuation at $529.2M (range $337.5M to $810.0M, 13% confidence), based on comparable companies in the sector.
How much funding has Ridge Bio raised?
Ridge Bio has raised a total of $135M in funding. The most recent round on record is Seed.
Where is Ridge Bio headquartered?
Ridge Bio is headquartered in San Francisco, United States.
When was Ridge Bio founded?
Ridge Bio was founded in 2021.
What industry does Ridge Bio operate in?
Ridge Bio operates in Biotech, MedTech, HealthTech, Gene Therapy, Drug Discovery, Genomics.
What is Ridge Bio's current status?
Ridge Bio's current operating status is: Inactive.
No comments yet. Be the first to share your take.